- Home
- PCVX vs ATI Comparison
PCVX vs ATI Comparison
Compare PCVX & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- ATI
- Stock Information
- Founded
- PCVX 2013
- ATI 1960
- Country
- PCVX United States
- ATI United States
- Employees
- PCVX N/A
- ATI N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- ATI Steel/Iron Ore
- Sector
- PCVX Health Care
- ATI Industrials
- Exchange
- PCVX Nasdaq
- ATI Nasdaq
- Market Cap
- PCVX 4.4B
- ATI 7.3B
- IPO Year
- PCVX 2020
- ATI N/A
- Fundamental
- Price
- PCVX $35.76
- ATI $89.33
- Analyst Decision
- PCVX Strong Buy
- ATI Buy
- Analyst Count
- PCVX 10
- ATI 6
- Target Price
- PCVX $136.50
- ATI $77.60
- AVG Volume (30 Days)
- PCVX 1.5M
- ATI 1.9M
- Earning Date
- PCVX 08-05-2025
- ATI 07-31-2025
- Dividend Yield
- PCVX N/A
- ATI N/A
- EPS Growth
- PCVX N/A
- ATI 2.35
- EPS
- PCVX N/A
- ATI 2.76
- Revenue
- PCVX N/A
- ATI $4,463,600,000.00
- Revenue This Year
- PCVX N/A
- ATI $7.20
- Revenue Next Year
- PCVX N/A
- ATI $7.06
- P/E Ratio
- PCVX N/A
- ATI $32.38
- Revenue Growth
- PCVX N/A
- ATI 6.82
- 52 Week Low
- PCVX $27.66
- ATI $39.23
- 52 Week High
- PCVX $121.06
- ATI $89.46
- Technical
- Relative Strength Index (RSI)
- PCVX 57.77
- ATI 71.16
- Support Level
- PCVX $31.79
- ATI $87.04
- Resistance Level
- PCVX $36.89
- ATI $88.76
- Average True Range (ATR)
- PCVX 1.51
- ATI 1.98
- MACD
- PCVX 0.37
- ATI -0.14
- Stochastic Oscillator
- PCVX 77.65
- ATI 98.27
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About ATI ATI Inc.
ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.